Focus:
Uncategorised
-
9 December 2019
As prevalent cases of Multiple Sclerosis grow, new investment opportunities open up, says GlobalData
Multiple Sclerosis is an autoimmune disease affecting the central nervous system. The condition causes nerve sheath demyelination, followed by axon damage and paralysis. The symptoms of Multiple Sclerosis include muscle...
-
17 October 2019
From start-ups to the SIX Swiss Exchange – a Swiss success story
Switzerland is consistently ranked the most innovative country in the world, especially when it comes to life sciences. We look at how the country promotes the creation of new biotech...
-
20 September 2019
Alopecia Areata market set to be worth $1.7bn by 2028 driven by the launch of JAK inhibitors, says GlobalData
Alopecia Areata (AA) is a non-scarring form of alopecia which is also the second most common in the world. There are no clear reasons or causes for the development of...
-
20 September 2019
Global Hemophilia A and B market set to reach $9.3bn by 2028, says GlobalData
Hemophilia A and B are both rare, genetic disorders which are X chromosome linked and cause a deficiency in blood clotting factors VIII (FVIII) and IX (FIX). Hemophilia can be...
-
23 May 2019
-
23 May 2019
-
23 May 2019
-
-
4 April 2019
Northern India manufacturing on growth trajectory, but still lags behind south
Approximately 70% of all Indian pharmaceutical revenues will be from generics and revenue growth for this segment has been particularly rapid in recent years.
-
28 March 2019
How machine learning and IoT can help the world’s poorest people
Plummeting cost-to-compute is making machine learning and IoT applications more accessible than ever. Here's why that could benefit soceity's poorest.